Akkermansia muciniphila and GLP-1-Based Therapies: Bidirectional Interactions and Implications for Type 2 Diabetes and MASLD/MASH

Boris Dinkov

Open source

DOI
10.3390/biomedicines14061235
Published
2026-05-29
Container
Biomedicines
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/biomedicines14061235,
  title = {Akkermansia muciniphila and GLP-1-Based Therapies: Bidirectional Interactions and Implications for Type 2 Diabetes and MASLD/MASH},
  author = {Boris Dinkov},
  year = {2026},
  journal = {Biomedicines},
  doi = {10.3390/biomedicines14061235},
  url = {https://doi.org/10.3390/biomedicines14061235}
}

RIS

TY  - JOUR
TI  - Akkermansia muciniphila and GLP-1-Based Therapies: Bidirectional Interactions and Implications for Type 2 Diabetes and MASLD/MASH
AU  - Boris Dinkov
PY  - 2026
JO  - Biomedicines
DO  - 10.3390/biomedicines14061235
UR  - https://doi.org/10.3390/biomedicines14061235
ER  - 

APA

Dinkov, B. (2026). Akkermansia muciniphila and GLP-1-Based Therapies: Bidirectional Interactions and Implications for Type 2 Diabetes and MASLD/MASH. Biomedicines. https://doi.org/10.3390/biomedicines14061235

Source records